Pharmaceuticals: Shocks to the system
The pharmaceutical industry is going through a turbulent period. Patents protecting companies' blockbuster drugs are expiring - according to consultancy firm Evaluate Pharma, around half of the $383bn (£255bn)-worth of patented drugs sold worldwide last year will lose patent protection in the next five years - while barriers preventing makers of generic drugs from selling their own versions of leading products continue to fall.
Takeovers, restructurings and tougher regulation – lawyers working in the drugs industry are used to turbulent times. Alex Aldridge gets the perspective of the leading pharma clients facing up to major shifts within the industry
This premium content is reserved for
Legal Week Subscribers.
Subscribe today and get 10% off.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651